Dr. Samnotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
99 Lincoln St
Framingham, MA 01702Phone+1 508-383-8510Fax+1 508-383-8584
Education & Training
St Elizabeth's Medical CenterResidency, Internal Medicine, 1991 - 1993
UPMC Medical EducationInternship, Internal Medicine, 1989 - 1990
McGill University Faculty of MedicineClass of 1989
Certifications & Licensure
MA State Medical License 1993 - 2025
TX State Medical License 1997 - 2024
WY State Medical License 1997 - 2023
NH State Medical License 2001 - 2021
FL State Medical License 1996 - 2000
PA State Medical License 1996 - 2000
WV State Medical License 1997 - 1997
Clinical Trials
- Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC) Start of enrollment: 2004 Aug 01
- Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II T...Joyce F Liu, Stéphanie Gaillard, Andrea E Wahner Hendrickson, Oladapo Yeku, Elisabeth Diver
JCO Precision Oncology. 2024-05-01 - 4 citationsNiraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).Leslie M Randall, David M O'Malley, Bradley J Monk, Robert L Coleman, Stephanie Gaillard
Gynecologic Oncology. 2023-11-01 - 3 citationsEffect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors.Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, Sanjay Goel, Solmaz Sahebjam
Clinical Pharmacology in Drug Development. 2023-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
